SCHEMBL8848024

SCHEMBL8848024

O=CC=Cc1cc(O)c(O)c(C(F)(F)F)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABBR2 O75899 1/20 0.57
▸ GABBR1 Q9UBS5 1/20 0.57
▸ XDH P47989 2/20 0.49
▸ MMP2 P08253 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CDK4 P11802 2/20 0.40
▸ CCND1 P24385 2/20 0.40
▸ CCNB2 O95067 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ CCNB3 Q8WWL7 1/20 0.40
▸ APP P05067 2/20 0.36
▸ ALOX5 P09917 2/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NQO2 P16083 1/20 0.34
▸ ERN1 O75460 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8848018 1.00 GABBR2 (0.57) GABBR2GABBR1XDHMMP2ALDH1A1
SCHEMBL8848334 0.82 XDH (0.46) GABBR2GABBR1XDHALDH1A1KDM4E
SCHEMBL5849926 0.81 XDH (0.63) GABBR2GABBR1XDHMMP2ALDH1A1
SCHEMBL21996031 0.74 XDH (0.46) GABBR2GABBR1XDHALDH1A1KDM4E
SCHEMBL30799215 0.74 XDH (0.46) GABBR2GABBR1XDHALDH1A1KDM4E
SCHEMBL16610343 0.73 PELI1 (0.46) GABBR2GABBR1MMP2ALDH1A1KDM4E
SCHEMBL28818999 0.73 PELI1 (0.46) GABBR2GABBR1MMP2ALDH1A1KDM4E
SCHEMBL16610382 0.73 GABBR2 (0.40) GABBR2GABBR1APPALOX5ERN1
SCHEMBL14281153 0.73 XDH (0.53) GABBR2GABBR1XDHMMP2ALDH1A1
SCHEMBL9228329 0.73 GABBR2 (1.00) GABBR2GABBR1ALDH1A1MAPTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0444899-B1 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation ORION YHTYMAE OY (FI) 1997-02-05 — — EP claimed
EP-0444899-A2 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation ORION-YHTYMÀ„ OY (FI) 1991-09-04 — — EP claimed
EP-0444899-B1 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation ORION YHTYMAE OY (FI) 1997-02-05 — — EP disclosed
US-5489614-A MEDICINAL ANTIOXIDANTS USED IN PREVENTION AND TREATMENT OF TISSUE DAMAGE INDUCED BY LIPID PEROXIDATION ORION-YHTYMA OY (FI) 1996-02-06 — — US disclosed
EP-0444899-A2 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation ORION-YHTYMÀ„ OY (FI) 1991-09-04 — — EP disclosed
Send feedback